[1]
Al-Janabi, I. 2022. Response Challenges to Cancer Immunotherapies. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2, (Apr. 2022), 51–80. DOI:https://doi.org/10.54133/ajms.v2i.65.